Mizuho upgraded Corvus Pharmaceuticals (CRVS) to Outperform from Neutral with a price target of $12, up from $3.50. The firm significantly ...
Fintel reports that on October 22, 2024, Mizuho initiated coverage of Cadence Design Systems (NasdaqGS:CDNS) with a ...
Fintel reports that on October 22, 2024, Mizuho initiated coverage of Applied Industrial Technologies (NYSE:AIT) with a ...